LEADER 01570nam  2200385 a 450 
001 9910702154903321
005 20120926153112.0
035   $a(CKB)5470000002424589
035   $a(OCoLC)811142449
035   $a(EXLCZ)995470000002424589
100   $a20120926d2012      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aPharmacologic guidelines for treating individuals with post-traumatic stress disorder and co-occurring opioid use disorders$b[electronic resource]
210  1$a[Washington, D.C.] :$cU.S. Dept. of Health and Human Services, Substance Abuse and Mental Health Services Administration,$d[2012]
215   $a1 online resource (13 pages)
225 1 $aHHS Publication ;$vno. SMA-12-4688
300   $aTitle from title screen (viewed on Sept. 26, 2012).
320   $aIncludes bibliographical references (pages 7-10).
606   $aPharmacology$zUnited States
606   $aPost-traumatic stress disorder$xTreatment
606   $aOpioid abuse$xTreatment$zUnited States
615  0$aPharmacology
615  0$aPost-traumatic stress disorder$xTreatment.
615  0$aOpioid abuse$xTreatment
712 02$aUnited States.$bSubstance Abuse and Mental Health Services Administration.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910702154903321
996   $aPharmacologic guidelines for treating individuals with post-traumatic stress disorder and co-occurring opioid use disorders$93165639
997   $aUNINA